Carla - Proto-oncogenes Flashcards
What is the hypothetical series of events to form a cancer cell?
- Initial mutation inactivates a negative cell cycle regulator
- Next mutation overactivates a positive cell cycle regulator
- Third mutation inactivates a genome stability factor
- Additional mutations accumulate rapidly
- Cancer cell formed
What are proto-oncogenes?
Genes whose products promote cell growth and division
Positive cell cycle regulators
What do proto-oncogenes encode?
Transcription factors that stimulate expression of other genes
Signal transduction molecules that stimulate cell division
Cell-cycle regulators that move through the cell cycle
What is an oncogene?
A gene which can transform a cell into a tumour cell
What must happen to proto-oncogenes for them to become oncogenes?
They must gain an amplification or activating mutation that results in them gaining the ability to transform a cell into a cancer cell
What do oncogenes cause to happen to cells?
(4)
Hyperactive growth and division
Protection against apoptosis
Loss of respect for normal tissue boundaries
Ability to become established in diverse tissue environments
What causes the conversion of proto-oncogenes to oncogenes?
This happens through genetic alteration
It typically leaves a gene continuously switched on
Give five types of oncogenes
Ras
Myc
CDK4
BCR/ABL
BCL-2
What are the three RAS isoforms?
H-Ras
K-Ras
N-Ras
How does Ras acct as an oncogene?
The active or mutant versions are found in many cancers e.g. colorectal
What is Ras?
Gene that encodes p21
What are the two types of Myc?
c-Myc
N-Myc
How does Myc act an oncogene?
(3)
It is over expressed in colorectal and breast cancers
It is rearranged in lymphomas
It is amplified in breast cancers and neuroblastomas (n-Myc)
How does CDK4 act as an oncogene?
Its mutated in familial melanoma
It has sporadic mutations in other tumours
How does BCR/ABL act as an oncogene?
Chimeric gene produced from the fusion of genes through chromosomal rearrangements -> The Philadelphia Chromosome
Cause of most chronic myelogenous leukaemias